MJN is a company that designs, manufactures, and markets a non-invasive, discreet and portable device capable of predicting an epileptic crisis in advance. The system is designed to help people, and their families, who suffer from epilepsy, especially those who are not controlled by drugs and have a high probability of seizures.
Investors 1
| Date | Name | Website |
| - | Ship2B | ship2b.org |
Mentions in press and media 1
| Date | Title | Description |
| 11.07.2026 | Tech4Health alcanza los 20 millones de euros de financiación en sus siete ediciones | Junto a DKV Seguros, Medichem y Nestlé España abrimos la octava convocatoria del programa de inversión y aceleración Tech4Health. Las entidades organizadoras seleccionaremos las mejores startups y spin-off tecnológicas que contribuyan a mej... |